< Back | |
11 Mar 2015 | |
The Exchange had sought clarification from Dr Reddys Laboratories Ltd with respect to news appearing in Economic Times on March 11, 2015 titled "DRL may Buy UCB's India Ops for $135m."<BR><BR>Dr Reddys Laboratories Ltd replied stating "We would like to state that we do not comment on market speculations. Any M&A transaction or similar other event, if material in nature, will be communicated to the Stock Exchanges by the Company, at an appropriate time whenever it becomes certain." | |
View all announcements for DR.REDDY'S LABORATORIES LTD. | Source: BSE India |